Outcomes among a young population of pediatric asthma patients using controller therapies: Results from a retrospective database analysis

Pediatric Asthma, Allergy and Immunology

Volumn 20, Issue 4, 2007, Pages 211-221

  Bukstein, Don A ^a   Murphy, Kevin R ^b   Katz, Laura M ^c   Ramachandran, Sulabha ^d   Doyle, John J ^c   Stern, Lee S ^c  

^a DEAN MEDICAL CENTER   (United States)

^b Midwest Allergy and Asthma Clinic   (United States)

^c Analytica International   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ARTICLE; ASTHMA; CHILD HEALTH CARE; CONTROLLED STUDY; DATA BASE; DISEASE EXACERBATION; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL;

EID: 38649133384     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2006.024     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. Asthma prevalence, health care use and mortality, 2002. Available at: http://www.cdc.gov/nchs/products/ pubs/pubd/hestats/asthma/asthma.htm (Accessed April 3, 2006).
2. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002; 110:315-322.
3. Owens PL, Thompson J, Elixhauser A, Ryan K. Care of children and adolescents in U.S. hospitals. Rockville, MD: Agency for Healthcare Research and Quality; 2003.
4. Weinberger M. Clinical patterns and natural history of asthma. J Pediatr 2003; 142:S15-S19.
5. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326:862-866.
6. Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics 1992; 90:657-662.
7. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: Estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 1999; 104:957-963.
8. National Asthma Education and Prevention Program. Expert panel report: Guidelines for the diagnosis and management of asthma update on selected topics - 2002. J Allergy Clin Immunol 2002; 110:S141-S219.
9. Szefler SJ, Eigen H. Budesonide inhalation suspension: A nebulized corticosteroid for persistent asthma. J Allergy Clin Immunol 2002; 109:730-742.
10. Bender B, Wamboldt FS, O'Connor SL, et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000; 85:416-421.
11. Szefler SJ. Meeting the needs of the modernization act: challenges in developing pediatric therapies. J Allergy Clin Immunol 2000; 106:S115-S117.
12. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154:1349-1352.
13. Kemp JP, Kemp JA. Management of asthma in children. Am Fam Phys 2001; 63:1341-1348.
14. Barnes PJ. The size of the problem of managing asthma. Respir Med 2004; 98 S4-S8.
15. Berger WE, Shapiro GG. The use of inhaled corticosteroids for persistent asthma in infants and young children. Ann Allergy Asthma Immunol 2004; 92:387-399.
16. Bukstein D, Kraft M, Liu AH, Peters SP. Asthma end points and outcomes: what have we learned? J Allergy Clin Immunol. 2006; 118(4 Suppl):S1-S15.
17. ICD-9-CM. International classification of diseases, 9th revision, clinical modification, 5th ed. Salt Lake City, UT: Medicode Publications; 1999.
18. Redbook. Redbook (TM) for Windows, Version 5.0.: Micromedex Inc., Greenwood Village, CO; 2003.
19. HCPCS. Health care procedure coding system, national level II, Medicare codes, HCPCS Millennium Edition. Los Angeles, CA: Practice Management Information Corporation; 2003.
20. O'Connell EJ. Optimizing inhaled corticosteroid therapy in children with chronic asthma. Pediatr Pulmonol 2005; 39:74-83.
21. Szefler SJ, Lyzell E, Fitzpatrick S, Cruz-Rivera M. Safety profile of budesonide inhalation suspension in the pediatric population: Worldwide experience. Ann Allergy Asthma Immunol 2004; 93:83-90.
22. Bauman LJ, Wright E, Leickly FE, et al. Relationship of adherence to pediatric asthma morbidity among innercity children. Pediatrics 2002; 110:e6.
23. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114:1288-1293.
24. Berger WE, Legorreta AP, Blaiss MS, et al. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol 2004; 93:538-545.
25. Balkrishnan R, Christensen DB. A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use. J Asthma 2001; 38:91-98.
26. Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM. Impact of antidepressant drug adherence on comorbid medication use and resource utilization. Arch Intern Med 2005; 165:2497-2503.